Article

England's Queen Elizabeth II honors Allergan chairman/CEO

Queen Elizabeth II of England named British-born David E.I. Pyott, chairman of the board and CEO of Allergan Inc., in the Birthday Honours List last month. Pyott becomes a Commander of the Most Excellent Order of the British Empire.

Queen Elizabeth II of England named British-born David E.I. Pyott, chairman of the board and CEO of Allergan Inc., in the Birthday Honours List last month. Pyott becomes a Commander of the Most Excellent Order of the British Empire.

"This award acknowledges David Pyott's contribution to British business excellence and management skills in the United States," said Los Angeles-based British Consul-General Robert Pierce. "Under his leadership, Allergan's European headquarters has been relocated to the United Kingdom and this will eventually result in hundreds of high-quality new jobs, supporting the British government's aim of the promotion of our bio-pharma industry. He has also been tireless in advocating broader business links between Britain and California."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.